ArticleAlzheimer's research & therapy2025

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss.

Cinzia A Maschio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.